Outcomes associated with comorbid atrial fibrillation and heart failure in medicare beneficiaries with acute coronary syndrome

BMC Health Services Research

Volumn 14, Issue , 2014, Pages

  Chen, Shih Yin ^a   Crivera, Concetta ^b   Stokes, Michael ^a   Boulanger, Luke ^a   Schein, Jeff ^b  

^a EVIDERA   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Atrial fibrillation; Coronary disease; Heart failure; Medicare

Indexed keywords

ACUTE CORONARY SYNDROME; AGED; ATRIAL FIBRILLATION; COMORBIDITY; ECONOMICS; EPIDEMIOLOGY; FEMALE; HEALTH CARE COST; HEART FAILURE; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ACUTE CORONARY SYNDROME; AGED; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEDICARE; PATIENT OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84897629699     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-80     Document Type: Article

References (23)

1. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, Circulation 2012 125 2 e220 22179539
2. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Kolansky DM, Am J Manag Care 2009 15 36 S41 19355807
3. Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets. Ehrlich JR, Nattel S, Hohnloser SH, J Cardiovasc Electrophysiol 2002 13 399 405 10.1046/j.1540-8167.2002.00399.x 12033360
4. New-onset atrial fibrillation and acute coronary syndrome. Lau DH, Alasady M, Brooks AG, Sanders P, Expert Rev Cardiovasc Ther 2010 8 941 948 10.1586/erc.10.61 20602555
5. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ, Circulation 2003 107 2920 2925 10.1161/01.CIR. 0000072767.89944.6E 12771006
6. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE, JAMA 2001 285 2370 2375 10.1001/jama.285.18.2370 11343485
7. Atrial fibrillation and stroke in the general Medicare population: a 10-year perspective (1992 to 2002). Lakshminarayan K, Solid CA, Collins AJ, Anderson DC, Herzog CA, Stroke 2006 37 1969 1974 10.1161/01.STR.0000230607. 07928.17 16809573
8. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS, Circulation 2006 114 119 125 10.1161/CIRCULATIONAHA.105. 595140 16818816
9. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Kim MH, Johnston SS, Chu BC, Dalal MR, Schulman KL, Circ Cardiovasc Qual Outcomes 2011 4 313 320 10.1161/CIRCOUTCOMES. 110.958165 21540439
10. Forecasting the future of cardiovascular disease in the united states: a policy statement from the American Heart Association. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, Circulation 2011 123 933 944 10.1161/CIR.0b013e31820a55f5 21262990
11. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P, Am J Cardiol 2009 104 1317 1323 10.1016/j.amjcard.2009.06.055 19892044
12. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de Werf F, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB, Heart 2008 94 867 873 10.1136/hrt.2007.134486 18332062
13. Impact of atrial fibrillation in acute coronary syndromes. Torres M, Rocha S, Marques J, Nabais S, Rebelo A, Pereira MA, Azevedo P, Correia A, Rev Port Cardiol 2008 27 1407 1418 19227808
14. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont MC, Lopez-Sendon J, Budaj A, Goldberg RJ, Klein W, Anderson FA Jr, Circulation 2004 109 494 499 10.1161/01.CIR.0000109691.16944.DA 14744970
15. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA, GRACE Investigators, Am J Cardiol 2002 90 358 363 10.1016/S0002-9149(02)02489-X 12161222
16. A profile of the medicare current beneficiary survey. Adler GS, Health Care Financ Rev 1994 15 153 163 10138483
17. Practical considerations on the use of the charlson comorbidity index with administrative data bases. D'Hoore W, Bouckaert A, Tilquin C, J Clin Epidemiol 1996 49 1429 1433 10.1016/S0895-4356(96)00271-5 8991959
18. Review of statistical methods for analysing healthcare resources and costs. Mihaylova B, Briggs A, O'Hagan A, Thompson SG, Health Econ 2011 20 897 916 10.1002/hec.1653 20799344
19. Impact of congestive heart failure in patients with non-st-segment elevation acute coronary syndromes. Roe MT, Chen AY, Riba AL, Goswami RG, Peacock WF, Pollack CV Jr, Collins SP, Gibler WB, Ohman EM, Peterson ED, Am J Cardiol 2006 97 1707 1712 10.1016/j.amjcard.2005.12.068 16765118
20. Incremental cost burden to us healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors. Amin AN, Jhaveri M, Lin J, Adv Ther 2011 28 907 926 10.1007/s12325-011-0065-6 21971681
21. Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective. Lee WC, Lamas GA, Balu S, Spalding J, Wang Q, Pashos CL, J Med Econ 2008 11 281 298 19450086
22. Resource use in the last 6 months of life among Medicare beneficiaries with heart failure, 2000-2007. Unroe KT, Greiner MA, Hernandez AF, Whellan DJ, Kaul P, Schulman KA, Peterson ED, Curtis LH, Arch Intern Med 2011 171 196 203 10.1001/archinternmed.2010.371 20937916
23. Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004. Whellan DJ, Greiner MA, Schulman KA, Curtis LH, Circ Cardiovasc Qual Outcomes 2010 3 33 40 10.1161/CIRCOUTCOMES.109.854760 20123669